Tweetovi

Blokirali ste korisnika/cu @seoaneja

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @seoaneja

  1. proslijedio/la je Tweet
    31. sij

    I am excited to share my latest work on ! Here we try to understand how the mSWI/SNF, or the BAF complex, promotes polycomb-mediated repression? 1/n

    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    30. sij

    I am giving a short talk in the morning session on Chromatin Regulators & TOP2 inhibitors in breast cancer. A collaboration with & Thank you to & for the generous invitation.

    Prikaži ovu nit
    Poništi
  3. proslijedio/la je Tweet
    11. sij
    Odgovor korisniku/ci

    Alternatively, tax the super wealthy and corporations a reasonable amount, and pay for these kids to go to college, and provide free healthcare to all. That might actually improve the country, rather than laying off thousands of teachers and providing less education.

    Poništi
  4. proslijedio/la je Tweet
    16. pro 2019.

    Integrative analysis of early-stage patient and cell line data indicate chromatin regulatory genes that promote DNA accessibility are associated with anthracycline sensitivity

    Poništi
  5. proslijedio/la je Tweet
    15. pro 2019.

    Very excited to be named in this dogma-challenging paper list in the year 2019. Thank you! More evidences for early metastatic spread across cancer types are provided in our follow up study:

    Poništi
  6. proslijedio/la je Tweet
    13. pro 2019.

    Visit me at my poster! P4-07-01. If I am not here I may have been tempted away by some of the awesome posters at this session so tweet at me :)

    Poništi
  7. 25. stu 2019.
    Prikaži ovu nit
    Poništi
  8. 25. stu 2019.

    Outstanding work by featured as top 10 cancer research publications from EACR! Congrats Zheng and

    Prikaži ovu nit
    Poništi
  9. proslijedio/la je Tweet
    18. stu 2019.

    This links provides access to the full paper

    Prikaži ovu nit
    Poništi
  10. proslijedio/la je Tweet

    Expression of chromatin-regulatory genes mediates anthracycline sensitivity in women with : an analysis of a large metacohort of women with early stage disease:

    Poništi
  11. proslijedio/la je Tweet
    31. lis 2019.

    I'm very excited to share our latest preprint in the lab of . We performed a pan-cancer analysis on the clonality and timing of metastatic spread with 458 paired primary tumor or metastatic samples. 1/4

    Prikaži ovu nit
    Poništi
  12. proslijedio/la je Tweet
    13. stu 2019.

    Finally, our first paper on colorectal cancer phylogeography is out; here we tried to port techniques from evolutionary biology to describe cancer spread in a quantitative manner:

    Poništi
  13. proslijedio/la je Tweet
    9. stu 2019.

    Epigenetics dictating anthracycline sensitivity in breast cancer. Nice work!

    Poništi
  14. proslijedio/la je Tweet
    9. stu 2019.
    Odgovor korisnicima i sljedećem broju korisnika:

    Very proud of this collaborative effort led by the talented and . They are blazing new trails and both on the job market - so keep your eyes peeled!

    Poništi
  15. proslijedio/la je Tweet
    8. stu 2019.

    My co-first author paper with came out yesterday in . Preparing the mini-tweet storm ...

    Prikaži ovu nit
    Poništi
  16. proslijedio/la je Tweet

    Researchers show levels of epigenetic regulators modulating chromatin accessibility dictate sensitivity to anthracycline-based therapy in early and could help identifying patients deriving clinical benefit

    Poništi
  17. 7. stu 2019.

    We show a new mechanism that will allow us to stratify better breast cancer patients so they can get the right chemotherapy

    Prikaži ovu nit
    Poništi
  18. 7. stu 2019.

    We found that a subset of genes that modify accessibility to the DNA modify also the sensitivity to anthracyclines.

    Prikaži ovu nit
    Poništi
  19. 7. stu 2019.

    We use an orthogonal computational biology approach using data from cell lines and gene networks, and data from patients

    Prikaži ovu nit
    Poništi
  20. 7. stu 2019.

    Our paper showing how chromatin regulators modify response to anthracycline in breast cancer in out in !. Great collaboration between lab and Crabtree lab at .

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·